MyAverix Finance
SHE · Healthcare
ChengDa Pharmaceuticals Co. Ltd. (301201)
Drug Manufacturers - Specialty & Generic
ChengDa Pharmaceuticals Co. Ltd. (301201) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $7.17B, P/E ratio is 18.00, net margin is -13.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301201
ChengDa Pharmaceuticals Co. Ltd. (301201) — FAQ
What is ChengDa Pharmaceuticals Co. Ltd.'s market cap?
ChengDa Pharmaceuticals Co. Ltd. (301201) has a reported market cap of $7.17B (data as of 2026-03-29).
What is 301201's P/E ratio?
The price-to-earnings (P/E) ratio for ChengDa Pharmaceuticals Co. Ltd. (301201) is 18.00 (data as of 2026-03-29).
Does ChengDa Pharmaceuticals Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for ChengDa Pharmaceuticals Co. Ltd. (301201). Check the MyAverix Finance app for the latest dividend data.
What sector is ChengDa Pharmaceuticals Co. Ltd. in?
ChengDa Pharmaceuticals Co. Ltd. (301201) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301201 listed on?
301201 is listed on SHE.
What is ChengDa Pharmaceuticals Co. Ltd.'s net margin?
ChengDa Pharmaceuticals Co. Ltd. (301201) reports a net margin of -13.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.